Vehicle Control
Vehicle Control is a pharmaceutical drug with 34 clinical trials. Currently 5 active trials ongoing. Historical success rate of 95.8%.
Success Metrics
Based on 23 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
20
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.5%
23 of 26 finished
11.5%
3 ended early
5
trials recruiting
34
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Topical Icariin on Acne and Acne Scars
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails
Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
Clinical Trials (34)
Topical Icariin on Acne and Acne Scars
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE
A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails
Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye
A Study to Investigate the Safety and Efficacy of YY003 in Adults with Moderate to Severe Glabellar Lines
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects
Nesvategrast (OTT166) in Diabetic Retinopathy (DR)
Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
Nasal and Systemic Immune Responses to Nasal Influenza Vaccine
Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease
A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia
Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 34